questionText: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 June to Question 61301 on Alzheimer's Disease: Drugs, whether NICE has made an assessment of the potential impact of not publishing the economic models for (a) lecanema
answerText: The National Institute for Health and Care Excellence’s (NICE) single technology appraisal process relies on information provided by companies to evaluate the clinical and cost-effectiveness of new treatments. Some of this information, including the econo...
heading: Alzheimer's Disease: Drugs